|Articles|May 1, 2002
- Applied Clinical Trials-05-01-2002
Identifying and Documenting Adverse Events at Clinical Study Sites
Improving adverse event reporting can lead to improved safety profiles and, consequently, fewer drugs pulled from the market.
Advertisement
Articles in this issue
about 24 years ago
Letters to the Editorabout 24 years ago
Parents for Orphansabout 24 years ago
Fraud, Abuse, and Consentabout 24 years ago
Brian Koziolabout 24 years ago
A Model-Based Method for Improving Protocol QualityAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
3
Quantifying the Net Financial Value of Deploying Risk-Based Quality Management
4
AI-Driven Clinical Trial Recruitment and Design
5